2026年9月
-
豚の腎臓を移植で透析なしで271日過ごした
Biotechnology, eGenesis, end-stage kidney disease, FDA clinical trial, gene-edited pig kidney, Harvard Medical School, immunosuppression, Japan healthcare implications, kidney xenograft, Massachusetts General Hospital, Mike Curtis, organ shortage, pig-to-human organ transplant, porcine organ, regenerative medicine, The Lancet, Tim Andrews, transplant medicine, transplant rejection, UKidney, United Therapeutics, xenograft survival, xenotransplantation
eGenesis社は遺伝子編集された豚腎臓を移植した患者が、その後人間の腎臓移植を受け成功したと発表しました。…
-
トランプ「最恵国薬価」政策、対象26社のリスト
AbbVie, Alcon, amgen, Astellas, AstraZeneca, BeOne Medicines, Biotech, Boehringer Ingelheim, BridgeBio, Bristol Myers Squibb, CSL, drug price reform, drug pricing, Eli Lilly, EMD Serono, Genentech, Gilead Sciences, GLP-1, GSK, healthcare affordability, healthcare policy, Japan pharma, Johnson & Johnson, Kyowa Kirin, MAHA, Medicaid, Merck, MFN, midsize biotech, Midsized Biotech Alliance of America, midterm elections, Most Favored Nation, novartis, novo nordisk, pfizer, pharma stocks, Pharmaceutical Industry, PhRMA, Regeneron, RFK Jr., Robert F. Kennedy Jr., sanofi, Sun Pharma, Takeda, tariffs, TEVA, Trump, TrumpRx, UCB, US politics
トランプ大統領の「最恵国薬価」政策により、2026年8月31日までに26社がアメリカの薬価を国際基準に合わせる…
